By helping individuals achieve and maintain a healthier weight, Tirzepatide supports overall health and reduces the risk of obesity-related complications
To fill this gap, FLOW is a randomized, double-blind, phase 3b trial of semaglutide 1.0 mg in patients with type 2 diabetes and chronic kidney disease, which evaluated the primary composite renal outcome of kidney failure, at least a 50% reduction in estimated glomerular filtration rate, or death from kidney or cardiovascular causes
Comprehensive snake venomics of the Okinawa Habu pit viper, Protobothrops flavoviridis , by complementary mass spectrometry-guided approaches
B12 is vital for proper function and development of the brain, bone density, vision, and more